Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XKH001 in Healthy Adult Caucasian Participants
NCT07757659Phase 1Not yet recruiting
- Sponsor
- Kanova
- Start
- Aug 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of XKH001 Placebo Injection (2 cohorts), sponsored by Kanova. Primary endpoints: Primary Outcome 1 at Day 57, Primary Outcome 2 at Day 57 and 17 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
XKH001 Placebo Injection
Beyond the preview
Go deeper on NCT07757659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757659.